XTX Topco’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

XTX Topco’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,398	Closed	-$12K	–	2625
2024 Q1	$12K	Buy	+1,398	New	+$6.68K	﹤0.01%	1663

Other funds holding TCON

GPFA

Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

XTX Topco's TCON Position: Q2 2024 in Review

XTX Topco sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 1,398 shares — an estimated $12K sold.

XTX Topco first reported a position in TCON in Q1 2024 and held it in 1 quarter. The position peaked at $12K in Q1 2024. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

XTX Topco reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
XTX Topco sold 1,398 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $12K.
XTX Topco first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
XTX Topco's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $12K in Q1 2024.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.